Facts & Comparisons eAnswers website. What the drug trials revealed. Cholesterol: high cholesterol facts. More than 100 anatomy articles feature clinical images and diagrams of the human body's major systems and organs. Plus, more than 600 drug monographs in our drug reference include integrated dosing calculators. This protein breaks down cholesterol receptors in liver cells that are responsible for removing LDL cholesterol from a person’s blood. Updated October 2015. Medscape is the leading online destination for healthcare professionals seeking clinical information. In: Circulation. Customize your Medscape account with the health plans you accept, so that the information you need is saved and ready every time you look up a drug on our site or in the Medscape app. Clinical trials.gov website. /publications/health-system-edition/2016/May2016/PCSK9-Inhibitors, Copyright Specialty Pharmacy Times 2006-2019, 2 Clarke Drive Suite 100 Cranbury, NJ 08512 P:609-716-7777 F:609-716-9038. cdc.gov/cholesterol/facts.htm. Approximately 73.5 million adults in the United States have a high level of low-density lipoprotein cholesterol. The clinical information represents the expertise and practical knowledge of top physicians and pharmacists from leading academic medical centers in the United States and worldwide. Our Drug Interaction Checker provides rapid access to tens of thousands of interactions between brand and generic drugs, over-the-counter drugs, and supplements. Bridgewater, NJ: Sanofi-Aventis; 2015. Mathon J. PCSK9 race: Amgen, Sanofi, and Regeneron first out of the gate, but Pfizer poised to make up lost ground. Medscape Reference features 129 medical calculators covering formulas, scales, and classifications. All material on this website is protected by copyright, Copyright © 1994-2020 by WebMD LLC. Discontinue use if hypersensitivity occurs. Drug images are also included. Choose from our complete list of over 1800 insurance plans across all 50 US states. PCSK9-Inhibitoren . Click on citations within drug and disease topics in our clinical reference to review the clinical evidence on MEDLINE. Approximately 73.5 million adults in the United States have a high level of low-density lipoprotein cholesterol (LDL-C). Dadurch kann das Enzym nicht mehr an die LDL-Rezeptoren binden. By hampering PCSK9's ability to work, they allow more LDL receptors to remain in the liver—and with more receptors available to sweep away LDL, a person's blood levels of LDL plummet. Updated March 17, 2015. They bind to and inactivate an enzyme in the liver called proprotein convertase subtilisin kexin 9 (PCSK9). Thousand Oaks, CA: Amgen Inc; 2015. PCSK9-Hemmer binden selektiv an die zirkulierende PCSK9 oder verhindern ihre Transkription in der Zelle. CLICK HERE for more information on drug interactions. Once upon a time when evolocumab was the only drug available in this class, it was mainly used to treat a genetic condition called familial hyperchol…hypercholester…too much cholesterol in the blood. If you log out, you will be required to enter your username and password the next time you visit. The American Journal of Pharmacy Benefits. Praluent [package insert]. Hundreds of image-rich slideshow presentations visually engage and challenge readers while expanding their knowledge of both common and uncommon diseases, case presentations, and current controversies in medicine. Plus, search the MEDLINE database for journal articles. Accessed February 26, 2016. They can also facilitate physician-patient discussions. Alirocumab and Evolocumab; No significant drug interactions are known; Metabolism and elimination; PCSK9 inhibitors are proteins, and they are metabolized through proteolytic pathways to smaller peptides and individual amino acids… All content is free. It's important to block PCSK9 because it inactivates the needed receptors on the liver cell surface that transport LDL into the liver for metabolism (break down). Blom DJ, Hala T, Bolognese M, et al; DESCARTES Investigators. Drug images are also included. Accessed March 9, 2016. Kereiakes DJ, Robinson JG, Cannon CP, et al. PCSK9 inhibitors have shown efficacy in lowering LDL-C levels and may be a viable option for patients requiring LDL lowering in addition to statin therapy, diet, and exercise. The articles assist in the understanding of the anatomy involved in treating specific conditions and performing procedures. : Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association. ... directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. Evolocumab; Alirocumab: Aktuell in ... Wiggins et al. Accessed February 2016. PCSK9 inhibitors are monoclonal antibodies (MABs), a type of biologic drug.